Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis

NCT: NCT04986605 · RECRUITING

NCT IDNCT04986605
StatusRECRUITING
Start Date2025-05-14
Completion2029-07
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to assess feasibility, safety and preliminary efficacy of Extracorporeal Photopheresis in the treatment of active diffuse cutaneous systemic sclerosis (dcSSc). This pilot study will help to determine if further study (a RCT) is justified.

Frequently Asked Questions

What is Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis?

Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis is a clinical trial registered under NCT04986605. Current status: RECRUITING.

What is the status of NCT04986605?

The current status of NCT04986605 (Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis) is: RECRUITING.

When did Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis start?

Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis started on 2025-05-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑